Barchart.com
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Menu
alerts false
Stocks | Futures | Watchlist | News | More
 
Advanced search
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

60 Degrees Pharmaceuticals Inc WT (SXTPW)

60 Degrees Pharmaceuticals Inc WT (SXTPW)
0.0348 x 79 0.0376 x 15
Post-market by (Cboe BZX)
0.0376 +0.0028 (+8.05%) 04/11/25 [NASDAQ]
0.0348 x 79 0.0376 x 15
Post-market 0.0376 unch (unch) 11:45 ET
News & Headlines for Fri, Apr 11th, 2025
Notes
Alerts
Watch
    Add or delete the symbol from one or more Watchlists.
  • Create New Watchlist
    This name already in use.
Help
Go To:
Geoff Dow, PhD, Infectious Disease Product Development Expert, to Discuss Babesiosis at Healing Lyme Summit, April 15-21 GlobeNewswire - Thu Apr 10, 7:31AM CDT

SXTP : 2.96 (-4.52%)
SXTPW : 0.0376 (+8.05%)
Sixty Degrees Pharmaceuticals Announces Patent License Agreement to Advance Development of Tafenoquine for Babesiosis Treatment and Prevention with Yale School of Medicine and Yale School of Public Health GlobeNewswire - Tue Apr 8, 7:31AM CDT

SXTP : 2.96 (-4.52%)
SXTPW : 0.0376 (+8.05%)
60 Degrees Pharmaceuticals Announces 2024 Annual Results GlobeNewswire - Fri Mar 28, 5:59AM CDT

SXTP : 2.96 (-4.52%)
SXTPW : 0.0376 (+8.05%)
60 Degrees Pharmaceuticals, Inc. Announces 1:5 Reverse Stock Split GlobeNewswire - Thu Feb 20, 9:36AM CST

SXTP : 2.96 (-4.52%)
SXTPW : 0.0376 (+8.05%)
Sixty Degrees Pharmaceuticals to Ensure Continuity of Tafenoquine Supply in U.S. by Importing Limited Quantity of KODATEF® GlobeNewswire - Tue Feb 11, 11:59AM CST

SXTP : 2.96 (-4.52%)
SXTPW : 0.0376 (+8.05%)
60 Degrees Pharma Announces Closing of $1.075 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules GlobeNewswire - Thu Feb 6, 1:07PM CST

SXTP : 2.96 (-4.52%)
SXTPW : 0.0376 (+8.05%)
60 Degrees Pharma Announces $1.075 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules GlobeNewswire - Wed Feb 5, 8:22AM CST

SXTP : 2.96 (-4.52%)
SXTPW : 0.0376 (+8.05%)
60 Degrees Pharma Announces Closing of $1.043 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules GlobeNewswire - Thu Jan 30, 1:20PM CST

SXTP : 2.96 (-4.52%)
SXTPW : 0.0376 (+8.05%)
60 Degrees Pharma Announces $1.043 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules GlobeNewswire - Wed Jan 29, 7:00AM CST

SXTP : 2.96 (-4.52%)
SXTPW : 0.0376 (+8.05%)
60 Degrees Pharma Announces IRB Approval of Phase II Study to Evaluate Tafenoquine for Chronic Babesiosis GlobeNewswire - Tue Jan 28, 7:01AM CST

SXTP : 2.96 (-4.52%)
SXTPW : 0.0376 (+8.05%)

Barchart Exclusives

This Nvidia-Backed AI Stock Is Shrugging Off Market Pain Thanks to the FDA. Should You Buy Shares Now? Barchart - 1 hour ago
Recursion Pharmaceuticals stock rallied as FDA announces plans of using AI for drug testing. Is it too late to invest in RXRX shares? Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
UTC
Reserve Your Spot